Please try another search
S2Medical AB (publ) develops, produces, and sells wound healing products for burns and chronic wounds in Sweden. It offers Epiprotect 2117, a synthetic allograft/xenograft substitute; Epiprotect Ulcer, a wound dressing consisting of a thin film of biosynthetic cellulose polymer intended to be used as a protective barrier for superficial wounds and deep wounds that have breached the dermis, as well as used as a temporary coverage for deep extensive wounds before transplantation or other surgical intervention. The company also provides washable, durable, waterproof, and self-adhesive bandages under the INSTABIND brand name, as well as NO SMELL, a perfume-free odour remover. The company also distributes Silverlon dressings that deliver a flow of silver ions into the wound; and BIOPAD, an ivory-white soft sponge, and BIOSPRAY, a medication powder form with spray. In addition, it operates the wound healing center under the S2Clinic name. The company was incorporated in 2013 and is headquartered in Linköping, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Mårten Skog | 39 | 2013 | Co-Founder, COO & Director |
Carsten Browall | 63 | 2018 | Director |
Patrick Sheehan | - | 2021 | Director |
Fredrik Skog | - | 2021 | Chair of the Board |
Chadi Asaad | - | 2021 | Director |
Miles Wright | - | 2021 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review